Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia

被引：3
|
作者：
Asou, N [1 ]
机构：
[1] Kumamoto Univ, Dept Hematol, Sch Med, Kumamoto 8608556, Japan
来源：
INTERNAL MEDICINE | 2005年 / 44卷 / 08期
关键词：
acute promyelocytic leukemia; all-trans retinoic acid; arsenic trioxide; PML-RA alpha;
D O I：
10.2169/internalmedicine.44.775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 776
页数：2
相关论文
共 50 条
  • [1] Treatment of Relapsed Acute Promyelocytic Leukemia by Arsenic Trioxide in Iran
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    Jahani, Mohamad
    Mousavi, Asadolah
    Iravani, Masoud
    Rostami, Shahrbano
    Ghaffari, Hamidolah
    Hosseini, Roholah
    Jalili, Mehdi
    ARCHIVES OF IRANIAN MEDICINE, 2011, 14 (03) : 167 - 169
  • [2] Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia
    Au, WY
    Kumana, CR
    Kou, M
    Mak, R
    Chan, GCF
    Lam, CW
    Kwong, YL
    BLOOD, 2003, 102 (01) : 407 - 408
  • [3] Cost-Effectiveness Of Arsenic Trioxide In The Treatment Of Relapsed/Refractory Acute Promyelocytic Leukemia In Canada
    Lachaine, Jean
    Mathurin, Karine
    Barakat, Stephane
    BLOOD, 2013, 122 (21)
  • [4] Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia
    Shigeno, K
    Nakamura, S
    Naito, K
    Yoshida, H
    Fujisawa, S
    Shinjo, K
    Fujita, Y
    Matsui, H
    Sahara, N
    Takeshita, A
    Ohno, R
    Ohnishi, K
    BLOOD, 2002, 100 (11) : 264B - 264B
  • [5] Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide
    Hirayama, Y
    Koyama, R
    Nagai, T
    Ohta, H
    Kondo, A
    Ishikawa, K
    Ishitani, K
    Matsunaga, T
    Sakamaki, S
    Niitsu, Y
    INTERNAL MEDICINE, 2001, 40 (11) : 1136 - 1139
  • [6] Arsenic Trioxide for the Treatment of a Relapsed Acute Promyelocytic Leukemia With Acute Renal Failure
    Yoon, Hoi Soo
    Park, Tae Sung
    Jeong, Kyung Hwan
    PEDIATRIC BLOOD & CANCER, 2011, 57 (06) : 1085 - 1085
  • [7] COST-EFFECTIVENESS OF ARSENIC TRIOXIDE IN THE TREATMENT OF RELAPSED/REFRACTORY ACUTE PROMYELOCYTIC LYMPHOMA LEUKEMIA IN CANADA
    Lachaine, J.
    Mathurin, K.
    Barakat, S.
    VALUE IN HEALTH, 2014, 17 (03) : A84 - A84
  • [8] Pharmacokinetics of arsenic trioxide (ATO) in patients with relapsed/refractory acute promyelocytic leukemia (APL).
    Soignet, S
    Bienvenu, B
    Warrell, RP
    Ellisson, R
    Spriggs, D
    Brannan, M
    CLINICAL CANCER RESEARCH, 2000, 6 : 4534S - 4534S
  • [9] Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide
    Fujisawa, Shinya
    Ohno, Ryuzo
    Shigeno, Kazuyuki
    Sahara, Naohi
    Nakamura, Satoki
    Naito, Kensuke
    Kobayashi, Miki
    Shinjo, Kaori
    Takeshita, Akihiro
    Suzuki, Yoshinari
    Hashimoto, Hisakuni
    Kinoshita, Kenji
    Shimoya, Masahito
    Kaise, Toshikazu
    Ohnishi, Kazunori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) : 485 - 493
  • [10] Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide
    O Galm
    U Fabry
    R Osieka
    Leukemia, 2000, 14 : 343 - 344
12345